Relation between emm types and virulence gene profiles among Bulgarian Streptococcus pyogenes clinical isolates

References

• Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–694.
   PubMed Web of Science ®Google Scholar
• Cunningham M. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511.
   PubMed Web of Science ®Google Scholar
• Golińska E, van der Linden M, Więcek G, et al. Virulence factors of Streptococcus pyogenes strains from women in peri-labor with invasive infections. Eur J Clin Microbiol Infect Dis. 2016;35:747–754.
   PubMed Web of Science ®Google Scholar
• Gergova RT, Muhtarova A, Mitov IG. Virulence potential of Bulgarian Streptococcus pyogenes clinical isolates. C R Acad Bulg Sci (Proc Bulg Acad Sci). 2015;68:1061–1070.
   Web of Science ®Google Scholar
• Ferretti JJ, McShan WM, Ajdic D, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001;98:4658–4663.
   PubMed Web of Science ®Google Scholar
• McMillan DJ, Drèze P-A, Vu T, et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect. 2013;19:E222–E229.
   PubMed Web of Science ®Google Scholar
• Beall B, Facklam R, Hoenes T, et al. Survey of emmgene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol. 1997;35:1231–1235.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Streptococcus pyogenes emm sequence database. Available at http://www.cdc.gov/ncidod/biotech/strep/types_emm103-124.htm
   Google Scholar
• Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959;110:271–292.
   PubMed Web of Science ®Google Scholar
• Muhtarova AA, Gergova RT, Mitov IG. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013–2016. J Glob Antimicrob Resist. 2017;10:238–242.
   PubMed Web of Science ®Google Scholar
• Muhtarova A, Gergova R, Setchanova L, et al. Distribution of super-antigens and toxins in Bulgarian invasive and non-invasive clinical isolates Streptococcus pyogenes. Acta Microb Bulgar. 2017;33:151–156.
   Google Scholar
• Anand TD, Rajesh T, Rajendhran J, et al. Super antigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. Ann Clin Microbiol Antimicrob. 2012;11:3. http://www.ann-clinmicrob.com/content/11/1/3
   PubMed Web of Science ®Google Scholar
• Commons R, Rogers S, Gooding T, et al. Superantigen genes in group A streptococcal isolates and their relationship with emm types. J Med Microbiol. 2008;57:1238–1246.
   PubMed Web of Science ®Google Scholar
• Descheemaeker P, Van Loock F, Hauchecorne M, et al. Molecular characterization of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993–1994. J Med Microbiol. 2000;49:467–471.
   PubMed Web of Science ®Google Scholar
• Luca-Harari B, Darenberg J, Neal S, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009;47:1155–1165.
   PubMed Web of Science ®Google Scholar
• Stathi A, Papaparaskevas J, Zachariadou L, et al. Prevalence of emm types 1 and 12 from invasive Streptococcus pyogenes disease in Greece-results of enhanced surveillance. Clin Microbiol Infect. 2008;14:808–812.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Arai K, Lee D-H, et al. Epidemiological study of erythromycin-resistant Streptococcus pyogenes from Korea and Japan by emm genotyping and multilocus sequence typing. Ann Lab Med. 2016;36:9–14.
   PubMed Web of Science ®Google Scholar
• Tamayo E, Montes M, García-Medina G, et al. Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis. 2010;10:233.
   PubMed Web of Science ®Google Scholar
• O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis. 2007;45:853–862.
   PubMed Web of Science ®Google Scholar
• Chan JC, Chu YW, Chu MY, et al. Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong. Pathology. 2009;41:681–686.
   PubMed Web of Science ®Google Scholar
• Paveenkittiporn W, Nozawa T, Dejsirilert S, et al. Prevalent emm types and super antigen gene patterns of group A Streptococcus in Thailand. Epidemiol Infect. 2016;144:864–869.
   PubMed Web of Science ®Google Scholar
• Cornick JE, Kiran AM, Vivancos R, et al. Epidemiological and molecular characterization of an invasive Group A Streptococcusemm32.2 outbreak. J Clin Microbiol. 2017;55:1837–1846.
   PubMed Web of Science ®Google Scholar
• Murakami J, Kawabata S, Terao Y, et al. Distribution of emm genotypes and super-antigen genes of Streptococcus pyogenes isolated in Japan, 1994–9. Epidemiol Infect. 2002;128:397–404.
   PubMed Web of Science ®Google Scholar
• Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–920.
   PubMed Web of Science ®Google Scholar
• Proft T, Fraser JD. Streptococcal super antigens: biological properties and potential role in disease. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: basic biology to clinical manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016.
   Google Scholar
• Chiang-Ni C, An-Bang W, Ching-Chuan L, et al. Emergence of uncommon emm types of Streptococcus pyogenes among adult patients in southern Taiwan. J Microbiol Immunol Infect. 2011;44:e424–e429.
   PubMedGoogle Scholar
• Chalker V, Jironkin A, Coelho J, et al. Genome analysis following a national increase in Scarlet Fever in England 2014. BMC Genomics. 2017;18:224.
   PubMed Web of Science ®Google Scholar
• Green NM, Beres SB, Graviss EA, et al. Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol. 2005;43:4083–4091.
   PubMed Web of Science ®Google Scholar
• Beres SB, Olsen RJ, Saavedra MO, et al. Genome sequence analysis of emm89 Streptococcus pyogenes strains causing infections in Scotland, 2010–2016. J Med Microbiol. 2017;66:1765–1773.
   PubMed Web of Science ®Google Scholar
• Koutouzi F, Tsakris A, Chatzichristou P, et al. Streptococcus pyogenes emm types and clusters during a 7-year period (2007 to 2013) in pharyngeal and nonpharyngeal pediatric isolates. J Clin Microbiol. 2015;53:2015–2021.
   PubMed Web of Science ®Google Scholar
• Turner CE, Abbott J, Lamagni T, et al. Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. mBio. 2015;6:e00622–15.
   PubMed Web of Science ®Google Scholar
• Zhu L, Olsen RJ, Nasser W, et al. A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Invest. 2015;125:3545–3559.
   PubMed Web of Science ®Google Scholar
• Steer AC, Carapetis JR, Dale JB, et al. Status of research and development of vaccines for Streptococcus pyogenes. Vaccine. 2016;34:2953–2958.
   PubMed Web of Science ®Google Scholar
• Steer AC, Dale JB, Carapetis JR. Progress toward a global Group A Streptococcal vaccine. Pediatr Infect Dis J. 2013;32:180–182.
   PubMed Web of Science ®Google Scholar
• Fernie-King BA, Seilly DJ, Willers C, et al. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology. 2001;103:390–398.
   PubMed Web of Science ®Google Scholar
• Lei B, De Leo FR, Reid SD, et al. Opsonophagocytosis-inhibiting mac protein of group A Streptococcus: identification and characteristics of two genetic complexes. Infect Immun. 2002;70:6880–6890.
   PubMed Web of Science ®Google Scholar